Initial anticoagulation therapy with direct oral anticoagulants in patients with intermediate-high-risk pulmonary embolism: from the COMMAND VTE Registry-2

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Ryo Shigeno

The Sakakibara Heart Institute of Okayama, Okayama (Japan)

6 More presentations in this session

Presentation thumbnail

Clinical long-term outcomes in fragile patients with venous thromboembolism receiving direct oral anticoagulant: From the COMMAND VTE Registry-2

Assistant Professor Y. Ogihara (Tsu, JP)

Abstract Slides Video

Presentation thumbnail

Three-year quality of life and the effect on functional limitation and anticoagulation adherence in patients with acute pulmonary emboli

Ms M. Mohammadi (Tehran, IR) Professor P. Sadeghipour (Tehran, IR)

Abstract Slides Video

Presentation thumbnail

Clinical features and long-term outcomes of venous thromboembolism in the warfarin era versus in the direct oral anticoagulant era

Doctor K. Kaneda (Kyoto, JP)

Abstract Slides Video

Presentation thumbnail

Different impact of each score component in the simplified PESI score on acute mortality of patients with pulmonary embolism in the era of direct oral anticoagulant

Doctor N. Ryusuke (Hamamatsu, JP)

Abstract Slides Video

Presentation thumbnail

Development and validation of a clinical prediction model for the diagnostic management of acute pulmonary embolism: an individual participant data meta-analysis.

Doctor G. Geersing (Utrecht, NL)

Abstract Slides Video

Access the full session

Session thumbnail

Current anticoagulation of acute pulmonary embolism: how does it impact outcomes?

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources